 Enalapril-associated anemia renal transplant recipients hypertension renal transplant recipient unexplained decrease hematocrit value enalapril hypertension drug experience previous similar case report review transplant patients enalapril patients unaccounted anemia pre-enalapril hematocrit value nadir value weeks initiation mg enalapril daily enalapril patients anemia weeks final hematocrit value patients enalapril physicians discretion decrease hematocrit values appreciable changes drug regimens clinical course laboratory parameters period causal relationship enalapril anemia effect drug withdrawal rechallenge hematocrit patients significant differences baseline clinical laboratory characteristics patients group group II enalapril-associated anemia exception normal hematocrit value group hematocrit value group II enalapril differential diagnosis anemia renal transplantation Susceptibility effect immunosuppressed state